Taking into account the Technology and Economic Assessment Panel’s expectation that production of metered-dose inhalers containing chlorofluorocarbons should cease by the end of 2009 and, based on its analysis and monitoring of the transition to chlorofluorocarbon-free treatments of asthma and chronic obstructive pulmonary disease over the last decade, the Panel’s assessment that global phase‐out of chlorofluorocarbon-based metered‐dose inhalers will be achievable by 2010,
Se irá solo, lo que soy yo, es no y noUN-2 UN-2